Did Russian COVID-19 vaccine complete clinical trials or phase I trials?

Russian coronavirus vaccine Moscow's medical university claims clinical trials complete

"We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are now underway", Tarasov noted. Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik that the first batch of volunteers will be discharged on Wednesday, whereas, the second will be discharged on July 20. The second group of 20 volunteers was vaccinated on June 23.

In the United Kingdom, two potential Coronavirus vaccine candidates have raised hopes. According to the HT report, Lukashev stated that the vaccine's safety is confirmed.

Similarly, a World Health Organisation document on "Draft landscape of COVID-19 candidate vaccines" lists two trials by the Gamaleya Research Institute as being Phase-I trials.

As the world is waiting eagerly for the Coronavirus vaccine, Russia's Sechenov University revealed that the clinical trials of the world's first vaccine against the novel Coronavirus have been completed.

When expectations were running high that it would be China, where the novel coronavirus had its origin in the city of Wuhan, unexpectedly Russian Federation has announced first to the world that its clinical trials are completed successfully and the vaccine is ready for production.

According to him, the first phase of human trials is going to begin in October, followed by the second phase from December to March 2021.

The vaccine is supposed to protect people and give them immunity against the virus for at least two years said Alexander Gintsburg, the director of the national research centre.

In China, there are four potential coronavirus vaccine candidates that are at different stages of development. The vaccine may get emergency-use authorization from the Food and Drug Administration and skip the third and final stage, which would use more than 10,000 volunteers in countries with an ongoing outbreak, according to Kiat. Subsequent phases expand testing exponentially and can run into years before determining a vaccine is safe for mass production.

"We have great scientists in Queensland and they are doing a remarkable job so we wish them all the very best as they undertake these trials", she said.